BG103704A - New compounds - Google Patents

New compounds

Info

Publication number
BG103704A
BG103704A BG103704A BG10370499A BG103704A BG 103704 A BG103704 A BG 103704A BG 103704 A BG103704 A BG 103704A BG 10370499 A BG10370499 A BG 10370499A BG 103704 A BG103704 A BG 103704A
Authority
BG
Bulgaria
Prior art keywords
new compounds
clavams
microorganisms
improving
processes
Prior art date
Application number
BG103704A
Other languages
Bulgarian (bg)
English (en)
Inventor
Barry Barton
John Griffin
Cecilia Anders
Susan Jensen
Roy MOSHER
Ashish Paradkar
Original Assignee
Smithkline Beecham P.L.C.
The Governors Of The University Of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C., The Governors Of The University Of Alberta filed Critical Smithkline Beecham P.L.C.
Publication of BG103704A publication Critical patent/BG103704A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG103704A 1997-02-04 1999-09-01 New compounds BG103704A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9702218.0A GB9702218D0 (en) 1997-02-04 1997-02-04 Novel product
PCT/EP1998/000644 WO1998033896A2 (en) 1997-02-04 1998-02-02 Microorganisms with increased production of clavulanic acid

Publications (1)

Publication Number Publication Date
BG103704A true BG103704A (en) 2000-05-31

Family

ID=10807030

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103704A BG103704A (en) 1997-02-04 1999-09-01 New compounds

Country Status (32)

Country Link
US (5) US6936458B1 (id)
EP (2) EP1405913A3 (id)
JP (2) JP4227199B2 (id)
KR (2) KR20050053794A (id)
CN (2) CN1696301A (id)
AP (1) AP1320A (id)
AR (2) AR011100A1 (id)
AT (1) ATE312926T1 (id)
AU (1) AU735782B2 (id)
BG (1) BG103704A (id)
BR (1) BR9807144A (id)
CA (1) CA2279207A1 (id)
DE (1) DE69832783T2 (id)
DZ (1) DZ2413A1 (id)
EA (1) EA003773B1 (id)
ES (1) ES2255149T3 (id)
GB (1) GB9702218D0 (id)
HU (1) HUP0001048A3 (id)
ID (1) ID22144A (id)
IL (1) IL131043A0 (id)
MA (1) MA24464A1 (id)
MY (1) MY140928A (id)
NO (1) NO993758L (id)
NZ (1) NZ336894A (id)
OA (1) OA11082A (id)
PL (1) PL334961A1 (id)
SK (1) SK105499A3 (id)
TR (1) TR199901862T2 (id)
TW (2) TW200307041A (id)
UY (2) UY24874A1 (id)
WO (1) WO1998033896A2 (id)
ZA (1) ZA98868B (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019959A1 (en) * 1999-09-16 2001-03-22 The Johns Hopkins University Improvement of clavulanic acid production
EP1228218A2 (en) * 1999-10-22 2002-08-07 Smithkline Beecham Plc 5r clavam producing microorganisms with deleted lat and cvm genes
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
CN107964522B (zh) * 2018-01-04 2020-12-08 上海交通大学 海洋链霉菌dut11及其抗补体活性应用
KR20220031043A (ko) 2019-07-05 2022-03-11 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 스트렙토미세스 클라불리게루스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
ES444948A1 (es) * 1975-02-07 1977-08-16 Glaxo Lab Ltd Un procedimiento para la separacion de impurezas contaminan-tes del acido clavulanico.
GB1585661A (en) 1976-06-08 1981-03-11 Glaxo Lab Ltd Clavam derivatives
JPS589679B2 (ja) 1977-02-24 1983-02-22 武田薬品工業株式会社 抗生物質の製造法
US4202819A (en) 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9020683D0 (en) 1990-09-22 1990-11-07 Univ Strathclyde Isolation of dna
CA2108113C (en) * 1993-10-08 2006-12-05 Susan E. Jensen Dna sequence encoding enzymes of clavulanic acid biosynthesis

Also Published As

Publication number Publication date
EA003773B1 (ru) 2003-08-28
US20030166175A1 (en) 2003-09-04
AU735782B2 (en) 2001-07-12
TW589377B (en) 2004-06-01
SK105499A3 (en) 2000-05-16
UY24874A1 (es) 2001-07-31
WO1998033896A2 (en) 1998-08-06
JP4227199B2 (ja) 2009-02-18
EA199900718A1 (ru) 2000-02-28
KR20000070723A (ko) 2000-11-25
MY140928A (en) 2010-02-12
US7344869B2 (en) 2008-03-18
MA24464A1 (fr) 1998-10-01
ES2255149T3 (es) 2006-06-16
GB9702218D0 (en) 1997-03-26
WO1998033896A3 (en) 1998-11-19
KR100514964B1 (ko) 2005-09-15
DE69832783D1 (de) 2006-01-19
IL131043A0 (en) 2001-01-28
CN1192107C (zh) 2005-03-09
ID22144A (id) 1999-09-09
AR011100A1 (es) 2000-08-02
JP5042186B2 (ja) 2012-10-03
US20030022321A1 (en) 2003-01-30
EP1405913A3 (en) 2004-08-04
PL334961A1 (en) 2000-03-27
EP0970198A2 (en) 2000-01-12
KR20050053794A (ko) 2005-06-08
CA2279207A1 (en) 1998-08-06
HUP0001048A3 (en) 2001-09-28
NO993758D0 (no) 1999-08-03
OA11082A (en) 2003-03-13
US20030124690A1 (en) 2003-07-03
AR018304A2 (es) 2001-11-14
CN1251612A (zh) 2000-04-26
CN1696301A (zh) 2005-11-16
AU6295398A (en) 1998-08-25
BR9807144A (pt) 2000-01-25
ATE312926T1 (de) 2005-12-15
AP9901614A0 (en) 1999-09-30
HUP0001048A2 (hu) 2000-08-28
TW200307041A (en) 2003-12-01
AP1320A (en) 2004-10-29
EP1405913A2 (en) 2004-04-07
US6936458B1 (en) 2005-08-30
UY25197A1 (es) 1998-11-27
NO993758L (no) 1999-08-03
JP2009022298A (ja) 2009-02-05
EP0970198B1 (en) 2005-12-14
TR199901862T2 (xx) 2000-12-21
NZ336894A (en) 2001-08-31
DZ2413A1 (fr) 2003-01-04
DE69832783T2 (de) 2006-07-20
JP2001511001A (ja) 2001-08-07
US20070298470A1 (en) 2007-12-27
ZA98868B (en) 1999-08-03

Similar Documents

Publication Publication Date Title
AU5783294A (en) Azacyclohexapeptide compounds
CA2145630A1 (en) Microorganisms for the production of tryptophan and process for producing the same
WO1999057325A3 (en) Enzymes mixture
AU5485698A (en) Oxyiminopregnancarbolactone
AU4631596A (en) Process for the microbiological production of pha-polymers
MX9700257A (es) Nuevas estreptograminas y procedimiento de preparacion de estreptograminas por mutasintesis.
MY117381A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
BG103704A (en) New compounds
AU5426599A (en) Phosphoepoxides, method for making same and uses
WO1998013009A3 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
AU3109300A (en) Production of ascorbic acid using yeast
AU6820096A (en) Selective process for the deacylation of acylated compounds
AU4912799A (en) Process for the production of mannitol by immobilized micro-organisms
AU8631698A (en) A process for the preparation of tetraazamacrocycles
EP0911415A3 (en) Microbiological manufacture of L-ascorbic acid
ZA200005110B (en) Process for preparing intermediates.
WO2001042250A3 (en) Process for production of diphenyl-dialkoxysilane, phenylalkyl-dialkoxysilane, octaphenylcyclotetrasiloxane and sym-tetraalkyltetraphenyl-cyclotetrasiloxane
AU3814800A (en) Enantiomers of mercapto lactones and processes for their synthesis
YU67203A (sh) Derivati caloporosida, postupak za njihovu proizvodnju i njihova primena
AU646934B2 (en) Novel 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
HK1049026A1 (zh) L-薄荷醇的製備方法
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
CA2189682A1 (en) Process for producing trans-4-hydroxy-l-proline
BG102599A (en) Macrocyclic compounds produced from suboxide units
WO1999007199A3 (de) Verfahren zur herstellung von l-alaninol und gamma-glutamylisopropylamid und mikroorganismusstamm des genus pseudomonas